Search Orphan Drug Designations and Approvals
-
| Generic Name: | PEGylated recombinant human tumor necrosis factor-related apoptosis inducing ligand |
|---|---|
| Date Designated: | 09/05/2019 |
| Orphan Designation: | Treatment of chronic pancreatitis. |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Theraly Fibrosis, Inc. 20271 Goldenrod Lane, Suite 2046 Germantown, Maryland 20876 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







